Leadership Team

Ian StevensChief Executive Officer

Ian Stevens is a graduate of Edinburgh University, former Royal Air Force officer and chartered accountant who worked for KPMG in Oxford and Prague from 1991 to 1997.

Between 1998 and 2007 Ian was employed by Optos plc, a medical technology company specialising in the imaging of the retina, firstly in the role of CFO in Dunfermline, Scotland, and then from 2003 as General Manager, North America in Boston, USA.

From 2007 to 2010 Ian was CEO of Mpathy Medical, a surgical medical device company and in 2011 he joined prosthetic hand manufacturer, Touch Bionics, as CEO. Mpathy was sold to Danish surgical medical device manufacturer Coloplast in 2010 and Touch Bionics was sold to Icelandic Orthotic and Prosthetic manufacturer Ossur in 2016.

Mark LivingstoneChief Operating Officer

Mark joined the management team at Bsolve Dental in December 2014 as the Technical Director and he has over 20 years’ experience in the Pharmaceutical and Device Industry in a number of technical managerial roles. Mark also has experience of a variety of dosage forms and has extensive working knowledge of formulating products with controlled release characteristics. He has been involved in the research stages of projects through to full commercialisation and is co-author to a number of patents. Mark has a degree in Chemical Physics and an MBA from Strathclyde School of business.

Alastair HunterFinance Director

Alastair has been involved in the business since 2018 and became Finance Director in January 2021. Alastair trained in practice where he completed his ACCA qualification and has 10 years of various industry experience in high growth companies.

Melissa PeloquinDirector of Operations, North America

Melissa brings nearly 20 years’ experience working in the medical devices sector. She has experience building organizations within the optometry/ophthalmology, women’s heath, dermatology/skin cancer and most recently bionic prosthetics sector. She has held leadership positions focused in both Operations & Human Resources and is registered as a Certified Professional in Human Resources by the Human Resources Certification Institute as well as Society for Human Resources Management.

Board of Directors

David AtkinsonNon executive director

David is a co-founder of Circadia Ventures LLP which manages Tate & Lyle Ventures LP a London-based fund backed by the global food ingredients company Tate & Lyle. He has a background in investment banking with a specific focus on the food industry. David spent 14 years as an equity research analyst specifically focused on the food processing industry before co-founding Stamford Partners in 1998. Stamford Partners is a leading investment banking firm providing merger & acquisition and strategic consulting services to the European food industry. David has also held several senior management positions in the European equities operations of NatWest Markets and Bank of America Securities, as well as acting as a consultant to HSBC and the VC industry. Currently he serves on the Board of Nutriati Inc. as well as Bsolve Dental.

Ian StevensChief Executive Officer

Ian Stevens is a graduate of Edinburgh University, former Royal Air Force officer and chartered accountant who worked for KPMG in Oxford and Prague from 1991 to 1997.

Between 1998 and 2007 Ian was employed by Optos plc, a medical technology company specialising in the imaging of the retina, firstly in the role of CFO in Dunfermline, Scotland, and then from 2003 as General Manager, North America in Boston, USA.

From 2007 to 2010 Ian was CEO of Mpathy Medical, a surgical medical device company and in 2011 he joined prosthetic hand manufacturer, Touch Bionics, as CEO. Mpathy was sold to Danish surgical medical device manufacturer Coloplast in 2010 and Touch Bionics was sold to Icelandic Orthotic and Prosthetic manufacturer Ossur in 2016.

Mark LivingstoneChief Operating Officer

Mark joined the management team at Bsolve Dental in December 2014 as the Technical Director and he has over 20 years’ experience in the Pharmaceutical and Device Industry in a number of technical managerial roles. Mark also has experience of a variety of dosage forms and has extensive working knowledge of formulating products with controlled release characteristics. He has been involved in the research stages of projects through to full commercialisation and is co-author to a number of patents. Mark has a degree in Chemical Physics and an MBA from Strathclyde School of business.

Alastair HunterFinance Director

Alastair has been involved in the business since 2018 and became Finance Director in January 2021. Alastair trained in practice where he completed his ACCA qualification and has 10 years of various industry experience in high growth companies.